AMPHOTERICIN LIPOSOMAL RAN amphotericin B (amphotericin) 50mg powder for injection vial

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

amphotericin B, Quantity: 50 mg

Disponibil de la:

Sun Pharma ANZ Pty Ltd

Forma farmaceutică:

Injection, powder for

Compoziție:

Excipient Ingredients: cholesterol; sodium succinate hexahydrate; dl-alpha-tocopherol; sucrose; hydrogenated soy phosphatidylcholine; sodium hydroxide; hydrochloric acid; 1,2-distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) sodium

Calea de administrare:

Intravenous Infusion

Unități în pachet:

10 x vials + 10x 5 micrometre sterile filters, Single vial and single 5 micrometre sterile filter

Tip de prescriptie medicala:

(S4) Prescription Only Medicine

Indicații terapeutice:

AMPHOTERICIN LIPOSOMAL RAN is indicated for:,? prophylaxis in liver transplant patients at risk of systemic Candida, Aspergillus and Cryptococcus infections, and for,? the treatment of systemic fungal infections caused by organisms susceptible to Amphotericin B (See section 5.1 PHARMACODYNAMIC PROPERTIES, Clinical Trials).,AMPHOTERICIN LIPOSOMAL RAN is indicated for empirical treatment of presumed fungal infections in febrile neutropaenic patients whose fever has failed to respond to broad spectrum antibiotic treatment.,AMPHOTERICIN LIPOSOMAL RAN is indicated for the treatment of visceral leishmaniasis. Clinical studies of efficacy in visceral leishmaniasis are limited to Leishmania infantum.

Rezumat produs:

Visual Identification: Yellow coloured lyophilized mass or powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statutul autorizaţiei:

Registered

Data de autorizare:

2023-03-15